Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Taking thalidomide out of rehab

Thalidomide, a drug reviled in the 1960s for its teratogenic effects, has been revived in recent years for cancer and leprosy therapy. A study now finds another use for this drug in vascular disease, providing further insights into the drug's mechanisms of action (pages 420–428).

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Thalidomide bypasses the requirement of the TGF-β1–endoglin–Alk-1 signaling pathway for vascular stability.

Kim Caesar

References

  1. 1

    Vargesson, N. Bioessays 31, 1327–1336 (2009).

    Google Scholar 

  2. 2

    D'Amato, R.J., Loughnan, M.S., Flynn, E. & Folkman, J. Proc. Natl. Acad. Sci. USA 91, 4082–4085 (1994).

    Google Scholar 

  3. 3

    Deeken, J.F. et al. Pharmacogenomics J. advance online publication, doi:10.1038/tpj.2009.57 (29 December 2009).

  4. 4

    Lebrin, F. et al. Nat. Med. 16, 420–428 (2010).

    Google Scholar 

  5. 5

    Flieger, D., Hainke, S. & Fischbach, W. Ann. Hematol. 85, 631–632 (2006).

    Google Scholar 

  6. 6

    Mitchell, A. et al. Liver Transpl. 14, 210–213 (2008).

    Google Scholar 

  7. 7

    Daniel, T.O., Gibbs, V.C., Milfay, D.F. & Williams, L.T. J. Biol. Chem. 262, 11893–11896 (1987).

    Google Scholar 

  8. 8

    Hirschi, K.K., Burt, J.M., Hirschi, K.D. & Dai, C. Circ. Res. 93, 429–437 (2003).

    Google Scholar 

  9. 9

    Li, X. et al. Anticancer Res. 23, 2481–2487 (2003).

    Google Scholar 

  10. 10

    Rogers, M.S., Rohan, R.M., Birsner, A.E. & D'Amato, R.J. FASEB J. 17, 2112–2114 (2003).

    Google Scholar 

  11. 11

    Tang, Y. et al. Hum. Mol. Genet. 12, 1579–1589 (2003).

    Google Scholar 

  12. 12

    Bourdeau, A. et al. Am. J. Pathol. 158, 2011–2020 (2001).

    Google Scholar 

  13. 13

    Rohan, R.M., Fernandez, A., Udagawa, T., Yuan, J. & D'Amato, R.J. FASEB J. 14, 871–876 (2000).

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rosemary J Akhurst.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Akhurst, R. Taking thalidomide out of rehab. Nat Med 16, 370–372 (2010). https://doi.org/10.1038/nm0410-370

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing